About Actin, aortic smooth muscle
Actin, aortic smooth muscle (ACTA2) is a protein
from Homo sapiens identified by UniProt accession
P62736, 377 residues long.
MolForge cross-references it against 0 known binders and
362 disease associations.
Target properties
| Protein name | Actin, aortic smooth muscle |
| UniProt accession | P62736 |
| Gene | ACTA2 |
| Organism | Homo sapiens |
| Length | 377 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (362)
Diseases linked to this target (Open Targets).
- multisystemic smooth muscle dysfunction syndrome · score 0.79
- aortic aneurysm, familial thoracic 6 · score 0.78
- Moyamoya disease 5 · score 0.77
- familial thoracic aortic aneurysm and aortic dissection · score 0.70
- Rare disease with thoracic aortic aneurysm and aortic dissection · score 0.67
- Rare genetic vascular disease · score 0.57
- thoracic aortic aneurysm · score 0.54
- Familial hemophagocytic lymphohistiocytosis · score 0.41
- autoimmune lymphoproliferative syndrome · score 0.37
- connective tissue disease · score 0.36
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P62736-F1 | alphafold | PREDICTED | 95.35 | — |
Amino-acid sequence (377 residues)
MCEEEDSTAL VCDNGSGLCK AGFAGDDAPR AVFPSIVGRP RHQGVMVGMG QKDSYVGDEA QSKRGILTLK YPIEHGIITN WDDMEKIWHH SFYNELRVAP EEHPTLLTEA PLNPKANREK MTQIMFETFN VPAMYVAIQA VLSLYASGRT TGIVLDSGDG VTHNVPIYEG YALPHAIMRL DLAGRDLTDY LMKILTERGY SFVTTAEREI VRDIKEKLCY VALDFENEMA TAASSSSLEK SYELPDGQVI TIGNERFRCP ETLFQPSFIG MESAGIHETT YNSIMKCDID IRKDLYANNV LSGGTTMYPG IADRMQKEIT ALAPSTMKIK IIAPPERKYS VWIGGSILAS LSTFQQMWIS KQEYDEAGPS IVHRKCF
Explore Actin, aortic smooth muscle with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets